Presentation is loading. Please wait.

Presentation is loading. Please wait.

Age-Standardised Ten-Year Net Survival, Selected Cancers, Adults (Aged 15-99), England and Wales, 2010-2011 Breast is for female only. Laryngeal is for.

Published byShanna Sullivan Modified over 6 years ago

Similar presentations

Presentation on theme: "Age-Standardised Ten-Year Net Survival, Selected Cancers, Adults (Aged 15-99), England and Wales, 2010-2011 Breast is for female only. Laryngeal is for."— Presentation transcript:

1 Age-Standardised Ten-Year Net Survival, Selected Cancers, Adults (Aged 15-99), England and Wales, Breast is for female only. Laryngeal is for male only Ten-year survival for and is predicted using an excess hazard statistical model Survival for bowel cancer is a weighted average derived from data for colon (C18) and rectum cancer (C19-C20, C21.8) Source: cruk.org/cancerstats You are welcome to reuse this Cancer Research UK statistics content for your own work. Credit us as authors by referencing Cancer Research UK as the primary source. Suggested style: Cancer Research UK, full URL of the page, Accessed [month] [year].

Download ppt "Age-Standardised Ten-Year Net Survival, Selected Cancers, Adults (Aged 15-99), England and Wales, 2010-2011 Breast is for female only. Laryngeal is for."

Similar presentations

Age-Standardised One-, Five- and Ten-Year Net Survival, Selected Cancers, Adults (Aged 15-99), England and Wales, 2010-2011 Five- and ten-year survival.

Age-Standardised One-, Five- and Ten-Year Net Survival, Selected Cancers, Adults (Aged 15-99), England and Wales, Five- and ten-year survival.
Sinus Cancer (C30, C31): 2009-2013 One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-90, England 1-Year 5-Year 10-Year Ad Hoc Sex Survival (%)

Sinus Cancer (C30, C31): One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-90, England 1-Year 5-Year 10-Year Ad Hoc Sex Survival (%)
Breast Cancer (C50): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.

Breast Cancer (C50): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.
Age-Standardised Ten-Year Net Survival for the Most Common Cancers in Females, England and Wales, 2010-2011 Ten-year survival for 2010-2011 is predicted.

Age-Standardised Ten-Year Net Survival for the Most Common Cancers in Females, England and Wales, Ten-year survival for is predicted.
Mesothelioma (C45): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.

Mesothelioma (C45): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.
Hypopharyngeal Cancer (C12, C13):

Hypopharyngeal Cancer (C12, C13):
Eye Cancer (C69): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.

Eye Cancer (C69): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.
Uterine Cancer (C54-C55): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Females, UK Northern.

Uterine Cancer (C54-C55): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Females, UK Northern.
Colon Cancer (C18): 2000-2007 Age-Standardised Five-Year Relative Survival, Adults (Aged 15+), European Countries Data consists of both observed and predicted.

Colon Cancer (C18): Age-Standardised Five-Year Relative Survival, Adults (Aged 15+), European Countries Data consists of both observed and predicted.
Salivary Gland Cancer (C07, C08):

Salivary Gland Cancer (C07, C08):
Cancer of Unknown Primary (C77-C80): 2013

Cancer of Unknown Primary (C77-C80): 2013
Head & Neck Cancer (C00-C14, C30-C32): 2014

Head & Neck Cancer (C00-C14, C30-C32): 2014
Prostate Cancer (C61): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Males, UK Northern England.

Prostate Cancer (C61): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Males, UK Northern England.
Liver Cancer (C22): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales Scotland.

Liver Cancer (C22): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales Scotland.
Brain, Other CNS and Intracranial Tumours (C70-C72, C75. 1-C75

Brain, Other CNS and Intracranial Tumours (C70-C72, C75. 1-C75
Thyroid Cancer (C73): 2009-2013 One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-90, England 1-Year 5-Year 10-Year Survival (%) Survival (%) Survival.

Thyroid Cancer (C73): One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-90, England 1-Year 5-Year 10-Year Survival (%) Survival (%) Survival.
Age-Standardised Ten-Year Net Survival for the Most Common Cancers in Males, England and Wales, 2010-2011 Ten-year survival for 2010-2011 is predicted.

Age-Standardised Ten-Year Net Survival for the Most Common Cancers in Males, England and Wales, Ten-year survival for is predicted.
Gallbladder Cancer (C23-C24):

Gallbladder Cancer (C23-C24):
Uterine Cancer (C54-C55): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, Females, UK Northern.

Uterine Cancer (C54-C55): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, Females, UK Northern.
In Situ Breast Carcinoma (D05): 2014

In Situ Breast Carcinoma (D05): 2014

Similar presentations

Ads by Google